Salient Surgical Technologies, Inc. is a 220+ person rapidly growing medical technology company that develops and markets innovative Advanced Energy surgical products based on our proprietary Transcollation™ technology to improve patient outcomes in a wide range of surgical procedures. Our Transcollation™ technology transforms collagen at the molecular level, which when applied to blood vessels, creates a permanent mechanical seal.   This permanent seal 1) improves surgeons’ visualization – a key to MIS surgery; 2) significantly improves patients’ post-operative hemoglobin levels which in turn speeds recovery and reduces the need for blood transfusions. 

Over 300,000 patients have been treated with our devices to improve post-op hemoglobin levels and reduce blood loss in surgical oncology, orthopaedic reconstruction (hip and knee replacements) and instrumented spine procedures (fusions).   

Salient Surgical has focused on building strong future earnings power by: 

Developing advanced energy products that deliver high clinical and economic value, receiving 510(k) clearances with broad indications for use which permit us to quickly move into new market applications without facing additional regulatory hurdles, investing in post marketing studies that document the clinical and economic benefits of our products in a variety of surgical settings (for example, our studies demonstrate a greater than 70% reduction in blood transfusions for patients receiving a primary hip replacement), building a deep intellectual property portfolio (At present we have a total of 80+ patents either issued or filed), building a sales force selling a surgeon preference product and identifying new applications and product opportunities that leverage our core technology.

The company is well-capitalized and key investors to date include Medtronic, Arnerich Massena, RiverVest, Piper Jaffray, Vanguard Ventures, Crescendo, Memphis Biomed Ventures and QuestMark Partners.

To support our continued growth and expansion, we have a deep team of veteran medical device executives from companies such as Biogen IDEC, Covidien, Hewlett Packard, Johnson & Johnson, and Smith + Nephew.  The team has deep experience driving rapid growth with new technology, and has in turn built teams of high talent, high performance people throughout the organization.

In addition, the Company has a group of seasoned industry executives on its board of directors from companies such as:  Aspect Medical, Haemonetics, Medtronic, Target Therapeutics, Innovasive Devices and TranS1 Spine.

Quality Engineer

Essential Responsibilities:  

• Conducts evaluations and statistical tests to solve complex problems involving component and system interdependencies.  Provides statistical sampling size determinations.
• Conducts parametric and/or destructive physical analysis of failed parts in order to determine the root cause. Implements appropriate corrective actions.
• Assists in product risk management activities such as FMEAs and FTAs.

·         Assists in verification and validation activities.

·         Maps processes and assists in improving efficiency and quality.

·         Conducts internal and supplier audits and writes audit reports. 

·         Streamlines data collection and analysis. Automates data collection processes.

Desired Qualifications:

·         Bachelors degree Electrical Engineering

·         Two years medical device industry experience preferred but not mandatory.

·         Knowledge of quality systems principles, practices, and methods in a regulated product environment.

·         Knowledge of statistics for quality data analysis

·         Certified Quality Engineer (CQE) certification preferred.

·         Skill in operating the listed tools and equipment.

·         Ability to communicate effectively, orally and in writing, with employees and governmental agency representatives.  Ability to compile status reports.

Salient Surgical Technologies is an equal opportunity employer.